Company intelligence
Gossamer Bio
Vision * Connection * Innovation
Biotechnology Research
San Diego, US
130 employees
Founded 2017
1 public signals
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.
Verified activity
Signals from Gossamer Bio
1 published signal